Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term lansoprazole use for prevention of NSAID-associated gastric/duodenal ulcer recurrence
jRCT1080222368
- Sponsor
- Takeda
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lansoprazole in gastric ulcer, duodenal ulcer and Peptic ulcer disease (PUD), sponsored by Takeda.
02
Drugs
lansoprazole
03
Conditions
gastric ulcerduodenal ulcerPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on jRCT1080222368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222368.